SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-21-011356
Filing Date
2021-05-28
Accepted
2021-05-28 16:16:49
Documents
1
Period of Report
2021-05-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162223298726180.html 4  
1 FORM 4 wf-form4_162223298726180.xml 4 4721
  Complete submission text file 0001628280-21-011356.txt   6170
Mailing Address 4 EMBARCADERO CENTER SUITE 2100 SAN FRANCISCO CA 94111
Business Address
JANNEY DANIEL (Reporting) CIK: 0001198325 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35986 | Film No.: 21980411

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Issuer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations